Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.
Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.
复制标题
DOI:
10.1016/j.jmb.2013.09.037
复制
发表时间:
2014-01-23
影响因子:
5.6
通讯作者:
Bachmann, Andre S.
中科院分区:
文献类型:
--
作者:
Lange, Ingo;Geerts, Dirk;Feith, David J.;Mocz, Gabor;Koster, Jan;Bachmann, Andre S.
关键词:
Ornithine decarboxylase (ODC) is the sentinel enzyme in polyamine biosynthesis. Both ODC and polyamines regulate cell division, proliferation, and apoptosis. Sepiapterin reductase (SPR) catalyzes the last step in the biosynthesis of tetrahydrobiopterin (BH4), an essential cofactor of nitric oxide synthase (NOS), and has been implicated in neurological diseases but not yet in cancer. In this study, we present compelling evidence that native ODC and SPR physically interact, and we defined the individual amino acid residues involved in both enzymes using in silico protein-protein docking simulations. The resulting heterocomplex is a surprisingly compact structure, featuring two energetically and structurally equivalent binding modes both in monomer and dimer conformations. The novel interaction between ODC and SPR proteins was confirmed under physiological conditions by co-immunoprecipitation and co-localization in neuroblastoma (NB) cells. Importantly, we showed that siRNA-mediated knock-down of SPR expression significantly reduced endogenous ODC enzyme activity in NB cells, thus demonstrating the biological relevance of the ODC-SPR interaction. Finally, in a cohort of 88 human NB tumors we found that high SPR mRNA expression correlated significantly with poor survival prognosis using a Kaplan-Meier analysis (Logrank test P = 5 • 10−4), suggesting an oncogenic role for SPR in NB tumorigenesis. In conclusion, we showed that ODC binds SPR and thus propose a new concept in which two well-characterized biochemical pathways converge via the interaction of two enzymes. We identified SPR as a novel regulator of ODC enzyme activity, and based on clinical evidence present a model in which SPR drives ODC-mediated malignant progression in NB.
登录
查看更多内容
DOI:
10.1186/cc2955
发表时间:
2004-10
期刊:
Critical care (London, England)
影响因子:
--
作者:
Bewick V;Cheek L;Ball J
通讯作者:
Ball J
DOI:
10.1158/1078-0432.ccr-08-3213
发表时间:
2009-10-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Evageliou NF;Hogarty MD
通讯作者:
Hogarty MD
影响因子:
11.2
作者:
Friedman, Jennifer;Roze, Emmanuel;Blau, Nenad
通讯作者:
Blau, Nenad
影响因子:
64.8
作者:
AUVINEN, M;PAASINEN, A;HOLTTA, E
通讯作者:
HOLTTA, E
影响因子:
14.9
作者:
Barrett T;Troup DB;Wilhite SE;Ledoux P;Rudnev D;Evangelista C;Kim IF;Soboleva A;Tomashevsky M;Marshall KA;Phillippy KH;Sherman PM;Muertter RN;Edgar R
通讯作者:
Edgar R